SILVA PHARMACEUTICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 BDT | +1.17% |
|
+1.76% | -19.91% |
| Sales 2022 | 779M 6.63M 9.06M | Sales 2023 | 717M 6.1M 8.34M | Capitalization | 2.95B 25.1M 34.32M |
|---|---|---|---|---|---|
| Net income 2022 | 102M 868K 1.19M | Net income 2023 | 33M 281K 384K | EV / Sales 2022 | 4.02 x |
| Net cash position 2022 | 162M 1.38M 1.89M | Net cash position 2023 | 120M 1.02M 1.39M | EV / Sales 2023 | 3.95 x |
| P/E ratio 2022 |
32.2
x | P/E ratio 2023 |
89.1
x | Employees | 765 |
| Yield 2022 |
1.24% | Yield 2023 |
0.46% | Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.17% | ||
| 1 week | +1.76% | ||
| Current month | +1.76% | ||
| 1 month | +16.89% | ||
| 3 months | -3.35% | ||
| 6 months | -19.91% | ||
| Current year | -19.91% |
1 week
16.30
17.80
1 month
14.9019.00
Current year
13.4021.60
1 year
13.4021.60
3 years
13.4028.60
5 years
13.4028.60
10 years
13.4037.90
| Managers | Title | Age | Since |
|---|---|---|---|
Saira Khan
CEO | Chief Executive Officer | 43 | 17-03-11 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | 47 | 13-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Silvana Mirza
CHM | Chairman | 46 | 01-04-23 |
Samina Mirza
BRD | Director/Board Member | 40 | 01-04-23 |
Farhana Mirza
BRD | Director/Board Member | 39 | 01-04-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 17.3 | +1.17% | 679,077 |
| 24-06-03 | 17.1 | 0.00% | 552,596 |
| 24-06-02 | 17.1 | +0.59% | 534,978 |
| 24-05-30 | 17 | +2.41% | 530,243 |
| 24-05-29 | 16.6 | -2.35% | 143,128 |
End-of-day quote Dhaka S.E., June 03, 2024
More quotes
Silva Pharmaceuticals Ltd. is a Bangladesh-based pharmaceuticals company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Anti pyretic, Anti-inflammatory Drugs, Anti ulcerants, Antiemetic, Gastroprokinetic, Anti histamine, Anti spasmodic expectorants, Vitamins and Minerals medicines which is selling mainly in local market. The Company produces approximately 187 generic medicines. Its products include tablet, capsule, liquid, and dry syrup. The Companyâs products include Actisal, Alvolex, Atechlor, Ambosil, Cipronil, Esosil, Duet, Esypan, Feosi-Z, Glicasil, Multitonic, Multi Gold, Lirel, Omesil, Metlife, Probac, RT-150, Xinoplex, Valpress, Vistasil M, Vasopin Plus, Zoxanid, and others.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -19.91% | 20.1M | |
| +42.83% | 750B | |
| +34.11% | 606B | |
| -5.70% | 356B | |
| +18.06% | 326B | |
| +4.63% | 286B | |
| +18.42% | 246B | |
| -2.90% | 213B | |
| +11.23% | 213B | |
| +2.43% | 167B |
- Stock Market
- Equities
- SILVAPHL Stock
